Apr. 13 at 5:26 PM
$RBRK - A 47% CAGR Compounder, But The Market Is Sleeping
Since its IPO,
$RBRK has seen revenue growth from
$175M to
$378M in just 8 quarters—that's a 47% CAGR! Yet, the stock is up only 25%, trailing the S&P’s 34% return during the same period.
Is the market underestimating this high-growth compounder, or is there something being overlooked? With that kind of revenue growth,
$RBRK could be flying under the radar. If it starts to catch up, this stock could have significant upside.
